Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It will all work out in the end...Keep the faith...
Chris, I think they will make it work. It will be a a swap of 1 share of Nanobac for 8 to 10 shares of DNAG. And with that the DNAG board will be satisfied because we (they) can continue their dreams to pillage and plunder until Nanobac goes below a penny. Then at the the end of the year it will be time for a reverse split again. When will it stop? It is a bad time for this to happen with the very tight credit environment. Wall Street is not lending and in fact firing people to make their books look good. There are a lot of bad things to come for big companies, not to mention our own. It is time to pay, I am glad as a sharholder I only have to pay with what I put in.
I hope I am wrong, I want to see this work. I have invested a lot of money in this dream. If it is gone..oh well...I would much rather see this work...I hope for the best...
Scottie
There will be no sea of green. DNAG may go up to .0046 or .0047 but that is it. That is far from a sea of green.
DNAG is not going to go above a penny unless NNBP goes over .10 a share before the deal is completed. From here on out the stock will walk in unison. If NNBP is .047 a share DNAG will trade at .0047 or in that area. The word is out, about 10 DNAG shares is equal to 1 NNBP share. Why do you believe the stock could go to a penny? We hold more shares on average than the "insiders" do. If the "insiders" believed in their company they would have held a majority of the shares. They don't, and now that I know that, I am sad.
Most of us here own a larger percentage of DNAG than the "insiders" do if this CNBC web site is correct.
http://www.cnbc.com/id/15837275?q=dnag
I remember a small company from years ago. They had this great new technology platform to operate in the cell phone arena. The company was Qualcomm and their new technology was CDMA. The industry laughed at them and said CDMA would not be the dominant technology in the cell phone arena.
Need I say more, Qualcomm's CDMA technology dominates the cell phone arena and earns a royalty from most wireless devices used today that uses their CDMA platform.
I see the same happening soon in the diabetes world as the Protectin platform is being used to diagnose and test future diabetic patients.
Diabetes is a huge market and our new company will stake its claim and generate huge revenue. I can envision the price of our new stock to be worth tens of dollars a share, not tenths of a dollar.
That is the way I see the future for our new company.
All the best,
Scottie
jolyn86,
I think I will have the shares I hold in DNAG reduced to 1/10th. So if I hold 3 million DNAG shares, if the deal is done, I will hold 300,000 NNBP shares.
I think the combined shares of the new company do have a great future. I made 2 posts in the last hour or two on the DNAG board that can explain why. I hope you read them.
I think our combined company has a great future, not only for us shareholders, but for the future diabetic patients that will need our new Protectin diagnostic test platform that our combined company will bring to market.
The future looks bright for our soon to be combined companies.
All the best,
Scottie.
I have done some early reading on the present HbA1c diabetes test and what companies profit from it. It looks like Siemens, and European company, is a big player in the diagnostics arena. In 2006 they has sales of about 8.2 billion (Euros) and profits of about 1 billion (Euros) in the diabetes diagnostics arena.
I am almost sure our new combined company will partner with a large pharmacutical company like Merck, to name one, to sell the new Protectin diabetes platform worldwide. Both companies will profit and our new company can use the revenues to work on more projects on their adjenda. PT-401 is one that comes to mind.
I think the future looks great for our combined company.
All the best....
Scottie
I do not expect DNAG stock to move up much from now unless Nanobac stock increases also. If Nanobac moved up to .06 Dnag would move up to .006 or so. With that being said I think the future of the combined companies looks bright. I like the sound of this:
“Dr Hector Gomez has been on the Company’s advisory board giving Nanobac the benefit of evaluating DNAG’s technologies and portfolio of products,” said Dr. Benedict Maniscalco, Co-Chairman and Chief Medical Officer of Nanobac Pharmaceuticals. “Combining our diagnostic portfolios, specifically DNAP’s Protectin™ and Nanobac’s NB2 has the potential to play a significant role in the early diagnosis of vascular disease and could potentially help in identifying early signs and progression of cardiovascular disease,” Dr. Maniscalco concluded.
"The Protectin(TM) test will be used to identify diabetics at risk of developing vascular complications," said Dr. Gomez, Chairman of DNAP. "Protectin(TM) is anticipated to become a new tool in the complex understanding of Diabetes and could potentially replace HbA1c, the current test used to evaluate glucose control. Combined with Nanobac's diagnostic portfolio, Protectin(TM) is expected to dramatically increase the physician's ability to diagnose patients at significant cardiovascular risk," concluded Dr. Gomez.
According to Global Industry Analysts, the international global diabetes diagnostic supplies market is expected to grow to US$15.4 billion by 2010. This indicates significant potential for the Protectin™ test. Additionally, cardiovascular diagnostics will see a high rate of growth also, increasing from $11.9 billion in 2007 to $21.4 billion by the end of 2012. The cardiovascular diagnostics market represents one of the largest sectors within the diagnostics industry, chiefly due to the high prevalence rate of and high mortality rate from cardiovascular disease.
The combined companies have the potential to produce revenues in the billions in the coming years. This will make even one tenth of our present DNAG shares we each hold worth millions in the future if everything is executed right by the combined company.
All the best...
Scottie
Good luck Jolyn. How many NNBP shares do you hold? Do you like this possible merger? I hope the future of our combined companies is bright and fruitful. I hope our dreams come true.
All the best...
Scottie
Nanobac, even though it is a penny stock, it has a cutting edge technology that is watched by the big pharma companies. It has technology that is cutting edge enough that it can be bought up by a big pharma for a few dollars or more a share just to pay the owners and keep them silent. From what I read, Nanobac technology can put a lot of the big pharma drugs on the ropes and prove them as ineffective, even though those drugs "passed the test" of the FDA. Nanobac has the potential to be bought out by a bigger pharmacutical company in the next few months. With DNAG as a part of it the price gets higher.
With the combined company they will bring Protectin to market. A diabetes diagnostic that has a multi billion dollar market worldwide.
More to come in this world of illusion and reality....
All the best....
Scottie
I posted on the DNAG board a quote that stated 60% of the Nanobac shares are held by company insiders including 42% held by the CEO. I do recall reading that Nanobac has only 10 employees. There could also be a large number of family and friends of the insiders that hold a large percentage of the rest of the shares outstanding. Since most of the shares are held by insiders they already know all the information needed and there is no need to speculate on ideas and opinions on a stock board like this. Just a thought as to why there is so little message traffic here.
All the best,
Scottie
Here is another major opinion and statement from a Pennystock Insider about Nanobac (From Nov. 29th, 2007):
"The big shots in this company have close to 60% of the stock openly God knows how many shares their family and friends own. They have driven off most of their origional investors like the Nutmeg Group and bargain prices (below0.10 per share).
They are now in a partnership with Merck and AstroZenica on something called the "High Risk Plaque Initiative" If Nanobac's theories of CNP's hold up they could seriously harm sales of many existing and in the pipeline drugs. Either of these huge companies could offer $2.00 per share for this 0.07 stock and only cost them less than a half a billion dollars. Almost pocket change for a huge body or research and patents to use or kill as they see fit. AND THAT'S MY THEORY."
I find this statement interesting about Nanobac, the company set to buy us out. We may be in for a nice ride and future return on our investment. I owned 3 million shares before the last 1 for 20 reverse split and I have slowly worked my position back up to 3 million now. I have invested about $70,000 in DNAG to this point. I do not care if I lose everything at this point. I guess it is not about money anymore. I would like to see their great science work out. Perhaps with Nanobac we will get recognition and get bought up by a bigger pharma. Perhaps that company will use the technology DNAG has today to save lives in the future from bad medicine.
Off to read more stuff...All the best....
Scottie
I went on the net to find out more about Nanobac and it may seem big pharma may be interested in their technology before DNAG was in the picture today. I will print a post from a Pennystock Insider (From Dec.6th, 2007):
"NO CHANCE FOR A HOSTILE TAKEOVER: Why should AstraZenica pay $1 to $2 for a $0.07 stock. Because about 60% of the stock is held within the company. The CEO alone has over 42% of the total stock issued and outstanding. He alone will set the price. So if anyone has any belief in, or fear of, CNP's they will have to pay his price. Nanobac has this field tied up three ways from Sunday. They have patients, copyrights and agreements from NASA which gives them the whole thing "on earth" So long as someone doesn't open a stock exchange on the moon it is Nanobac. "
I just thought that info would be interesting. It seems Nanobac has potential also. With DANG merged with Nanobac perhaps we can get bought up by an interested large pharma at a profitable price.
Off to read some more...All the best....
Scottie.
You can ad me to the list bro... Brothers In Arms in for 2 milion shares.
I was looking at how a company is valued by price to sales ratio. Large drug companies range from a 3-5 PSR. DNAP can get a higher ratio because our sales are growing year over year. With the spinoff and relief of debt from DNAPP they may be able to get a 10 -20 PSR. That would equal about .10-.15 a share for DNAG.
Still not a millionaire....but it can happen.....
Scott
How many shares will a DNAG shareholder get from the spinoff? My guess is 1 for 500 to 1 for 1000. If Dutchess only gets 2 million shares, the amount of shares to be issued must be really low.
DNAG has a great chance for them to be offered a similar deal soon. PT401, I think would carry a heavy price tag to a smart and rich drug company looking to get richer.....
ann441j, I like your post's too. Let's join our hands and hearts together and pray...and believe. We can make it happen. I have a very strong feeling with all the great investors involved here that we have enough positive energy combined to make this thing work. Keep the faith and live your dreams....Scott...
Preciouslife 1, if you can get Paul Allen to back the company then we DNAG investors all owe you a debt of gratitude. I enjoy reading your posts and like your style. I think there are a lot of great people here hoping and praying for a great outcome here. Believe and it will happen. DNAG can be the new Amgen or Genentech. Believe and it will happen, our hopes for this company will come true. We are brothers and sisters in arms...
All the best....Scott...
Earnings and revenue will make this stock go up. Potential drugs from their pipeline will make the stock go up and also make them a buyout target. I would prefer a buyout from Merck or another major drug company. Our board has ties with Merck. If pt401 and their other drug prospects are worth $$money$$ I can see Merck offering 1 share of their company for every 100 outstanding DNAG shares. So if you own 1 million shares of DNAG you will get 10,000 shares of Merck at the upper $40's a share, not a bad deal. Believe and it will happen....
I own 2 million shares.
It has been so long....any M2GEN deal will be a flop...
I second your request. I am surprised he has not banned him already with the gay bashing and name calling.
Right on Chris brother...
Unless you are a short term trader, you would not care about the short term chart. Are you a trader or a holder like your post name states?
You may be right. I feel a slow death here. I lost $80,000 here and own the shares that money purchased. I believed in something big, DNA PRINT, and it turned into a big loss. I do not know how the board can host a shareholder meeting and be able to look the long term shareholders in the eye. I own 2,000,000(most pre reverse split) shares and drive a small car and live in a small apartment. If I go to Sarasota, am I to praise their nice cars and nice jobs and nice life built on my purchase of their shares?
The only thing that will save us is better financing and the possibility of explosive revenues from our products..that is all..
Scott
Don't you think DNAG has presented the EPO potential to Merck already? We do not need scouts, we have people here within this company that have ties to Merck. They are all friends and I think a deal is in the works...Time will tell..Time is also an enemy....
All he Best
Scott
Stockholder101, If you hold shares in this company, then I love you like a brother. You have to stop posting this big announcement that is going to happen that has never happened. The only thing that will bring us up from penny land is true and sustainable revenue that will reoccur year over year from the products that we develop and have on the market. Revenues and earnings equals a higher sustainable stock price, not a fluff pr and a one day spike that ends in a collapse which you are hoping for so you can sell out at the high. I am not saying you would do that..in the words of Chris B...But Hey.... (and visualise a grey wolf barking at the moon.)
All he Best
Scott
I think with all the million dollar lawsuits out there filed due to the adverse side effects from the drugs by big pharma I think a test will not be a patients choice, it will be mandatory.
I think the stock went down quick because there were many short term shareholders that believed in stockholder101's hype about the city deal to come about last Thursday. Nothing happened and the city did not even mention it. The 10k was good because our revenues doubled but it was also bad because they are having financing problems. I think in the long run this company will work out and do well. Remember Sytkowski has 40 million shares and he is working on PT401. Do you think he wants to see his stake diluted and fall apart? I think we are close to a better financing deal or a partnership that will benefit all shareholders. There is a huge potential for this company and it's future and you can buy into it for only a penny a share. You have to buy and hold. When Warren Buffet bought a stock he would give it at least 5 years for the company to work out. I know there are shareholders that have held for that long and did not see anything except a reverse split and more dilution, I am one of them. Good things will happen to the people who have bought, held and waited. I think we are not far away from a partnership or a drug announcement that will send this stock much higher than it is today. Good things come to those that wait and believe....
All the best...
Scott
I am sure many posters on the board do have large positions in the company. Your view that if they do not sell and hold, is a good one and may result in a rise in share price. In the past the biggest seller of this stock was DNA Print itself. They have sold over a billion shares before the reverse split. They have sold hundreds of millions up until now. Now I think they realised that issuing more shares for financing will put the company under and that is why they have made some better financing moves like the "loan" on the Biofrontera stock. Do you think Sytkowski with his 40 million shares issued to him wants to see this company print 100 million shares a month to get by. I think we have reached the peak of share dilution and that is why we have alternative financing methods going on. Venture capital may also help us. In the end buy and hold the shares in the company you believe in is the way to go. Buy and sell for a hundredth of a penny profit gets old and can backfire. Believe and it will happen...hold for dollars...not for a penny move.
Scott
The only way we will break the chains from the MM having fun with this stock is with revenue and profits....they will soon come over time...
Scott
momo123, my prediction is the stock will go down on Thursday. Buy on the rumor and sell on the news... During this week it will not rise or fall much either. The only thing that will make this stock go up over time is not the Post's from Stockholder 101, but rather the progression of DNA Prints agenda for the company over time...Personalised Medicine....We are the leader and we will be allowed in the club...give it time......all the best!!!
Scott
johnnyfiber, I like to read the posts you have submitted lately. I wish I had the time and energy to do the research you do.
I was talking with this nice lady in our occupational health department, in the company I work at, and the topic turned into how much we hate our jobs and would love to retire. I made the comment that if the shares I own in Dna Print work out I may not have to work in the next few years. She was interested and wanted me to tell her more about this company. I started off by telling her about the crimes their technology has solved and then told her about the new Amber Alert partnership and on and on... Please know, she is a semi retired nurse of 25 years of service and when I mentioned "personalised medicine" her eyes lite up. She has witnessed first hand the bad reactions that pharmaceutical drugs have on patients that should not have been prescribed them. To make it short I gave her some brief drug areas they were working in and she was so excited about this company. I gave her the DNA Print website to explore some more. I also told her to never invest money in this company because I have said anything. I told her of the reverse split I endured and the long road to build up my share base again. She promised me she will do her own DD and perhaps buy some shares. The summary of the story, I think, it is nice how an everyday conversation with a nurse turned into what this company is doing... and she thought it was great and wanted to know more.
Personalised medicine is the area to be in for the years to come. We are in the best company, DNA Print Genomics, to bring it to life. ....All the best.....
Scott
Tell that to Dr. Sytkowski, to whom, DNA Print Genomics gave 40 million shares, or about 10% of the company to. They must have gave Dr. Sytkowski 10% of the company because PT401 will not work out, ever, and Dr Sytkowski accepted 10% of this company, instead of cash, because he felt PT401 will never be worth anything. See what I am saying... A man as smart and knowledgeable as DR. S in this area would not accept shares unless he thought there was some future value to the shares and the drug he was working on. There is some future value here. How much?? The market will tell over time.... All the best...
Scott
Stockholder101, I thought you were supposed to be in Vegas????? VEGAS BABY......
Ok, keep up the great work on your "crib"....All the best....
Scott
Great post.....
Nice wood trim on your "crib"...